A. Moshnikova

发表

Probe for the measurement of cell surface pH in vivo and ex vivo

D. Engelman, Michael Anderson, A. Moshnikova, 2016, Proceedings of the National Academy of Sciences.

Family of pH (low) insertion peptides for tumor targeting

Yana K Reshetnyak, D. Engelman, A. Moshnikova, 2013, Proceedings of the National Academy of Sciences.

Targeting Acidic Diseased Tissues by pH-Triggered Membrane-Associated Peptide Folding

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2020, Frontiers in Bioengineering and Biotechnology.

Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression

Jakub Toczek, A. Moshnikova, Y. Reshetnyak, 2022, Circulation research.

Targeted suppression of microRNA-33 in lesional macrophages using pH low-insertion peptides (pHLIP) improves atherosclerotic plaque regression

Jakub Toczek, A. Moshnikova, Y. Reshetnyak, 2020 .

Antiproliferative effect of pHLIP-amanitin.

A. Moshnikova, Y. Reshetnyak, O. Andreev, 2013, Biochemistry.

Antiproliferative E ff ect of pHLIP-Amanitin

A. Moshnikova, Y. Reshetnyak, O. Andreev, 2013 .

Novel ex vivo endoscopic near infrared fluorescence imaging method using pHLIP®/ICG in patients undergoing radical cystectomy for urothelial carcinoma of the bladder

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2017 .

Acidic environments trigger intracellular H+-sensing FAK proteins to re-balance sarcolemmal acid–base transporters and auto-regulate cardiomyocyte pH

A. Moshnikova, Y. Reshetnyak, O. Andreev, 2021, Cardiovascular research.

Targeting bladder urothelial carcinoma with pHLIP-ICG and inhibition of urothelial cancer cell proliferation by pHLIP-amanitin

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2022, Frontiers in Urology.

pHLIP Peptides Target Acidity in Activated Macrophages

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2022, Molecular Imaging and Biology.

Eradication of tumors and development of anti-cancer immunity using STINGa targeted by pHLIP

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2022, Frontiers in Oncology.

Tumor treatment by pHLIP-targeted antigen delivery

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2023, Frontiers in Bioengineering and Biotechnology.

T-cells produce acidic niches in lymph nodes to suppress their own effector functions

R. Gillies, Hao Wu, A. Moshnikova, 2020, Nature Communications.

Prognostic value of cytokines in COVID-19 associated pneumonia

A. Moshnikova, E. Surkova, V. Mazurov, 2021 .

Novel pH-Sensitive Cyclic Peptides

A. Moshnikova, Y. Reshetnyak, O. Andreev, 2016, Scientific Reports.

Comparative Study of Tumor Targeting and Biodistribution of pH (Low) Insertion Peptides (pHLIP® Peptides) Conjugated with Different Fluorescent Dyes

Natallia V. Katenka, A. Moshnikova, Y. Reshetnyak, 2016, Molecular Imaging and Biology.

Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP peptide ex vivo

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2016, Proceedings of the National Academy of Sciences.

Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis.

Jakub Toczek, A. Moshnikova, Y. Reshetnyak, 2019, JCI insight.

pHLIP peptide targets nanogold particles to tumors

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2012, Proceedings of the National Academy of Sciences.

Ex-vivo Imaging of Upper Tract Urothelial Carcinoma Using Novel pH Low Insertion Peptide (Variant 3), a Molecular Imaging Probe

A. Moshnikova, Y. Reshetnyak, O. Andreev, 2020, Urology.

The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions

D. Engelman, A. Harris, A. Moshnikova, 2015, Proceedings of the National Academy of Sciences.

Targeting breast tumors with pH (low) insertion peptides.

A. Moshnikova, Y. Reshetnyak, O. Andreev, 2014, Molecular pharmaceutics.

Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment

A. Moshnikova, Y. Reshetnyak, O. Andreev, 2014, Scientific Reports.

pH-sensitive pHLIP® coated niosomes

A. Moshnikova, Y. Reshetnyak, O. Andreev, 2016, Molecular membrane biology.

pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2020, Scientific Reports.

Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2018, Proceedings of the National Academy of Sciences.

pH (low) insertion peptide (pHLIP) targets ischemic myocardium

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2012, Proceedings of the National Academy of Sciences.

pHLIP-FIRE, a Cell Insertion-Triggered Fluorescent Probe for Imaging Tumors Demonstrates Targeted Cargo Delivery In Vivo

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2014, ACS chemical biology.

Ex-vivo Imaging of Upper Tract Urothelial Carcinoma Using Novel ICG-Var3 pHLIP Imaging Agent.

A. Moshnikova, Y. Reshetnyak, O. Andreev, 2020, Urology.

Alkaline nucleoplasm facilitates contractile gene expression in the mammalian heart

A. Moshnikova, Y. Reshetnyak, O. Andreev, 2022, Basic Research in Cardiology.

pH (low) insertion peptide (pHLIP) targets ischemic myocardium

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2012, Proceedings of the National Academy of Sciences.

Probe for the measurement of cell surface pH in vivo and ex vivo

D. Engelman, Michael Anderson, A. Moshnikova, 2016, Proceedings of the National Academy of Sciences.

pHLIP peptide targets nanogold particles to tumors

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2012, Proceedings of the National Academy of Sciences.

Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP peptide ex vivo

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2016, Proceedings of the National Academy of Sciences.

Comparative Study of Tumor Targeting and Biodistribution of pH (Low) Insertion Peptides (pHLIP® Peptides) Conjugated with Different Fluorescent Dyes

Natallia V. Katenka, A. Moshnikova, Y. Reshetnyak, 2016, Molecular Imaging and Biology.

The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions

D. Engelman, A. Harris, A. Moshnikova, 2015, Proceedings of the National Academy of Sciences.

Antiproliferative effect of pHLIP-amanitin.

A. Moshnikova, Y. Reshetnyak, O. Andreev, 2013, Biochemistry.

pHLIP targeted intracellular delivery of calicheamicin.

D. Engelman, A. Moshnikova, Y. Reshetnyak, 2024, International journal of pharmaceutics.

Genetic deficiency or pharmacological inhibition of miR-33 Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis protects from kidney fibrosis

Jakub Toczek, A. Moshnikova, Y. Reshetnyak, 2023 .

Targeting acidic pre-metastatic niche in lungs by pH low insertion peptide and its utility for anti-metastatic therapy

A. Moshnikova, Y. Reshetnyak, O. Andreev, 2023, Frontiers in oncology.